国产重组酵母乙型肝炎疫苗接种小学生的3年免疫效果观察

本文报告对２５８ 名小学生应用０、１、６ 月程序,接种２ 批国产酵母疫苗（５ μｇ／０．５ ｍ ｌ）,１ 批Ａｍ ｇｅｎ 酵母疫苗（１０ μｇ／ｍ ｌ）,１ 批Ｍ ＳＤ 酵母疫苗（５ μｇ／０．５ ｍ ｌ）的小学生免后３ 年（（Ｔ３６）效果观察。结果表明,Ｔ３６ 时抗体 ＧＭＴ（几何平均滴度）,Ａｍ ｇｅｎ 疫苗组（１４５．７５）显著高于 ２ 批国产疫苗（９２．１１、８３．５２）和Ｍ．Ｓ．Ｄ 苗组（７４．６２）,抗体ＧＭＴ 峰值显著低于Ａｍ ｇｅｎ 和Ｍ ．Ｓ．Ｄ 苗的２ 批国产酵母疫苗,与Ｍ．Ｓ．Ｄ 苗抗体ＧＭＴ 水平无显著差异（Ｐ＞ ０．０５）。抗体阳转率间各疫苗组均无显著差异（９３．１０％ ～７４．１４％ ）。本次随访结果表明,采用０,１,６ 免疫程序,国产酵母疫苗免后３ 年的抗体阳转率和抗体ＧＭＴ水平不低于进口同类酵母疫苗的水平。     

国产与法国Merieux产伤寒Vi多糖菌苗人体接种反应及血清抗体应答比较

作者对国产伤寒Ｖｉ多糖菌苗和法国Ｍｅｒｉｅｕｘ产伤寒Ｖｉ多糖菌苗人体接种反应及血清抗体应答情况进行比较,接种后６～８小时法国菌苗的体温反应同国产菌苗相比有显著性差异（ｘ２＝５．３４７,０．２５＞Ｐ＞０．０１）,２４小时后反应消失,免后一月国产菌苗和法国菌苗Ｖｉ抗体四倍增长率分别为９１．８０％和８９．６％（ｘ２＝０．１６４,Ｐ＞０．０５）,ＧＭＴ分别为３６．９４和３５．４９（ｔ＝０．６５３,Ｐ＞０．０５）,二者均无显著性差异。     

青海南部太白韭4居群的核型研究

研究了葱属太白韭青海４个居群的染色体数目和核型。结果如下,居群１：２ｎ＝２ｘ＝１６＝１２ｍ＋２ｓｍ＋２ｓｔ（２ＳＡＴ）,居群２：２ｎ＝２ｘ＝１６＝１４ｍ＋２ｓｔ（２ＳＡＴ）;居群３：２ｎ＝４ｘ＝３２＝２４ｍ＋４ｓｍ＋４ｓｔ（４ＳＡＴ）,居群４：２ｎ＝２ｘ＝１６＝１４ｍ＋２ｓｔ（２ＳＡＴ）＋Ｂｓ（０－２）。并讨论了多倍体和Ｂ染色体形成与分析。     

联合应用生态制剂治疗感染性腹泻的临床研究

本文应用丽珠肠乐加整肠生联合治疗感染性腹泻,治愈率为９２．１％,与单一应用整肠生,治愈率（７３．１％）有显著性差异（ｘ￣２＝４．２４,Ｐ＜０．０５）,与氟哌酸组无明显差异（ｘ￣２＝３．０２,Ｐ＞０．０５）,单一整肠生组与氟哌酸组无明显差异（ｘ￣２＝０．２２,Ｐ＞０．０５）。生态制剂有良好确切疗效,两种生态制剂联合治疗,明显提高治愈率。感染性腹泻原因菌的分离结果,揭示了本地区感染性腹泻病原菌的多样化和复杂性,应用生态制剂联合治疗,优于抗生素治疗。     

承德市油松针叶硫及重金属含量动态及其与大气SO2之间的关系

本文分析了承德市油松（ＰｉｎｕｓｔａｂｕｔａｅｆｏｒｍｉｓＣａｒｒ．）针叶硫和重金属含量变化及其与大气ＳＯ＿２浓度之间的相关性,探讨了油松针叶对大气ＳＯ＿２的生物监测作用,结果认为：植物Ｓ含量生长末期＞休眠期＞生长初期＞生长旺盛期（ｐ＜０．００１）;重金属中Ｐｂ表现为类似的规律,Ｓ和Ｐｂ含量分别从０．７５ｍｇ·ｇ￣（－１）和０．７μｇ·ｇ￣（－１）上升到１．５８ｍｇ·ｇ￣（－１）和２．０μｇ·ｇ￣（－１）。Ｎｉ变化不明显;Ｚｎ、Ｃｕ和Ｆｅ呈下降趋势,但Ｚｎ在休眠期略有回升。Ｍｎ在休眠期最高,但生长期也很高,其余季节相对较低。这种变化特点与大气中ＳＯ＿２和总悬浮颗植物（ＴＳＰ）的变化趋势基本一致;油松针叶Ｓ含量与大气ＳＯ＿２浓度之间具有很显著的相关性,其中火车站监测点生长季节相关公式Ｙ＝－０．０２６３＋０．０９６５Ｘ（ｒ＝０．８９１１,ｐ＜０．００１）;城区Ｙ＝０．０１２６＋０．０６１８Ｘ（ｒ＝０．７８４１,ｐ＜０．０１）。利用后者可对整个承德市区的大气ＳＯ＿２污染状况进行生物监测。     

二氢玉米素核苷组细胞分裂素的放射免疫测定法

本文报道二氢玉米素核苷（ＤＨＺＲ）组细胞分裂素放射免疫测定法（ＲＩＡ）的研制结果。以（３Ｈ）二氢玉米素作示踪剂,测得免抗ＤＨＺＲ抗血清的效价为１：１３７０（Ｂ％＝３０％）。该抗血清主要与本组细胞分裂素发生交叉反应。回收率为９６．９％,灵敏度为１２ｆｍｏｌ ＤＨＺＲ／管,检测线性范围为０．１￣１００ｐｍｏｌＤＨＺＲ／管。批内误差ＣＶ＝４．３,批间误差ＣＶ＝２．０％。对基于同一免抗血清的ＤＨＺＲ组细胞     

黑鲷的胃排空率

在实验室内,１８℃条件下测量了体重在２０－４０ｇ的黑鲷的胃排空率,并用３种数学模型拟合了黑鲷的排空率,结果表明,３种模型都能很好地拟合实验数据,但通过统计学分析发现不论是用湿重还是用于重表示胃含物,线性模型都拟合得最好。用湿重表示时模型为Ｙ＝１．１４－０．０６ｔ（ｒ＾２＝０．８２,ｐ〈０．００１）;而用干重表示时模型为Ｙ＝１．３６－０．０７Ｔ（ｒ＾２＝０．６２,ｐ〈０．００１）,实验还得出体重２０     

三种毛茛的核型研究

对３种（含１变种）毛莨属植物进行了核型研究,其染色体数目及核型资料为首次报道。三叶毛莨（ＲａｎｕｎｃｕｌｕｓｊａｐｏｎｉｃｕｓＴｈｕｎｂ．ｖａｒ．ｔｅｒｎａｔｉｆｏｌｉｕｓＬ．Ｌｉａｏ．）有两种核型。即基本型２ｎ＝２ｘ＝１４＝６ｍ＋４ｓｍ＋４ｓｔ（２ＳＡＴ）和杂合型２ｎ＝２ｘ＝１４＝６ｍ＋４ｓｍ＋４ｓｔ（１ＳＡＴ）,前者核型的特征是其随体较大,而后者核型变异发生在第２对和第３对同源染色体异形上,并     

正常足月儿畸变产物耳声发射(DPOAEs)特性分析

研究提出正常足月儿畸变产物耳声发射（ＤＰＯＡＥｓ） 特性分析如下：１ ． ＤＰＯＡＥｓ 反应强度曲线,ＤＰ 图显示两个反应峰（ｆ２ ＝ １ ．６ 和５ ．０ ｋＨｚ） 和一个反应谷（ｆ２ ＝ ３ ．１ ～４ ．０ ｋＨｚ） ;２． ＤＰＯＡＥ 本底噪声及其特性,ｆ２ ＝ １．０ ｋＨｚ 其测试频率点（２ｆ１ －ｆ２） 本底噪声最高（Ｐ＜ ０ ．０５） ,ｆ２ ＝ ３ ．１ ,４．０ 和５ ．０ｋＨｚ ,测试频率点（２ｆ１ －ｆ２） 本底噪声较低（Ｐ＜ ０．０５） ;除ｆ２ ＝ ４．０ ｋＨｚ 外,ＤＰＯＡＥ 本底噪声与其反应强度均未呈现直线相关特性;３ ． ＤＰＯＡＥ ＳＮＲ 特性,ｆ２ ＝ １．０ ｋＨｚ 其ＳＮＲ 最小（Ｐ＝ ０．０００） ,ｆ２ ＝２ ．０ ｋＨｚ 其ＳＮＲ 最大（Ｐ０ ．００３） ;４． ＤＰＯＡＥ ＳＮＲ 和ＴＥＯＡＥ ＳＮＲ 相关特性,除１．０ ｋＨｚ 频段外,其余频段其二者间均有着非常显著的直线相关特性。     

沪191麻疹疫苗免疫持久性和影响因素的评价

１９９１～１９９８年,我们对荆州区川店镇５０３名６～１５月龄儿童进行了现行沪１９１麻疹疫苗血清流行病学效果观察,结果表明,初次免疫后１个月麻疹ＩｇＧ抗体阳转率为９１６５％,ＧＭＴ为１∶２６６７４,达保护滴度者比例为４６５％。随着时间的推移,第４年上述指标迅速下降到４６８６％、１∶１２７４和１８５％,第６年时低至２９４３％、１∶４８９和１３６％。０２ｍｌ、０３ｍｌ和０５ｍｌ麻疹疫苗组的近期和远期效果是类似的,初免后１个月时ＩｇＧ滴度越高,其免疫持久性越好;初免月龄是影响麻苗免疫效果的主要原因,６月龄初免组的免疫效果明显低于≥８月龄组。结果提示麻苗８月龄初免是可行的。     

HBsAg阴性母亲及其婴儿乙肝疫苗接种情况和免疫效果研究

目的：了解乙肝表面抗原阴性（HBsAg阴性）母亲及其婴儿乙肝疫苗接种情况及抗-HBs滴度水平,从而为今后针对该特殊人群进行更好的乙肝疫苗免疫策略提供依据。方法：2010年5月～2010年10月,对陕西省227对HBsAg阴性母亲及其婴幼儿（月龄为8～24月）进行流行病学调查并采集血液标本,对母婴血清抗-HBs进行定性及定量检测。结果：母亲乙肝表面抗体（抗-HBs）阳性率为45.4%,抗-HBs平均滴度为12.88 mIU/mL（95%CI：8.91-18.19）。婴儿乙肝疫苗首针、第二针和第三针的及时接种率分别为95.2%,93.8%和85.9%。婴儿抗-HBs阳性率为77.1%,抗-HBs平均滴度为37.15 mIU/mL（95%CI：28.18-48.98）。结论：婴儿乙肝疫苗首针及时接种率较高,但三针全程及时接种率仍需提高。母亲抗-HBs阳性率较低,应当重视HBsAg阴性孕龄妇女的乙肝疫苗接种及乙肝标志物的检测,从而提高该人群的乙肝免疫水平。     

Composition of acellular pertussis and combination vaccines: a general review.

Since the development and introduction of the acellular pertussis vaccine in Japan in the early eighties, we have come a long way in using this component in combination with other vaccines. However, the basic problem in development of an effective and safe pertussis vaccine is that the antigens to induce complete protection against clinical pertussis and the precise mechanism by which pertussis vaccine confers immunity is yet unknown. Hence, the composition of future acellular pertussis vaccine remains an open issue. Recently, acellular pertussis vaccine has been licensed for the booster doses in the U.S.A. and for primary immunization of infants in Italy and Germany. A multicentric trial has been carried out to compare the serological response and adverse reactions of 13 acellular pertussis vaccines. These vaccines contained one or more of the four components, i.e. FHA, PT, 69 kDa OMP and fimbriae. All vaccines were associated with substantially fewer and less adverse reactions and were more immunogenic with respect to antibodies against the added antigens. DTP vaccines in the near future will have combinations of other components and the key antigen for combination will be acellular pertussis component which is going to replace whole cell pertussis component in DTP vaccines. In view of this, manufacturers like ourselves from the developing countries are still groping in the dark, uncertain whether we should have a single component acellular pertussis vaccine or multicomponent one. This will have a major impact on the cost of production, the final cost of the combination vaccines and the regulatory issues that we will have to tackle in view of the recent thinking on harmonization in the pharmaceutical industry.     

Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response

In a previous study, using BALB/c mice, we found that while diphtheria (D), tetanus (T) and whooping cough (Pw, whole-cell Bordetella pertussis) immunization induces a Th1/Th2 tetanus response and memory T cells able to proliferate in response to in vitro stimulation with B. pertussis, DTPa immunization induces a Th2 tetanus immune response and no memory T cells that recognize B. pertussis as stimulus. Considering that a pro-inflammatory cytokine production is not necessary for protection against tetanus and therefore should be avoided, an alternative DTP immunization schedule with minimal Pw exposure was assessed in order to obtain a Th2 tetanus response and a Th1 pertussis response. BALB/c mice were primed with DT vaccine at day 0, with Pw vaccine at day 14 and boosted with DTPa vaccine at days 21 and 28. A control group was inoculated with saline. Antibodies against B. pertussis surface antigens, tetanus and diphtheria toxoids were produced by mice. Spleen cells stimulated in vitro with B. pertussis produced IL-6 and IFNgamma. Only IL-5 was produced by cells in response to tetanus toxoid stimulation. These results are in line with the low IgG1/IgG2a ratio for pertussis antibodies compared with those corresponding to tetanus and diphtheria. The immunization protocol presented herein succeeded in producing tetanus and pertussis immune responses of Th2 and Th1 type, respectively. In contrast to previous results obtained with DTPw immunization, no IL-12 production was observed. Our findings provide direct evidence that an immunization protocol with an interval of 14 days between DT and Pw primings, followed by DTPa boosters, can induce appropriate immune responses against DTP vaccine antigens.     

Protective efficacy of a whole cell pertussis vaccine

A trial of the efficacy of a plain whole cell pertussis vaccine was conducted in Sweden. In this non-blinded trial 525 infants aged 2 months who were born on days with an even number received three doses of vaccine one month apart and 615 infants of the same age who were born on days with an odd number were enrolled as controls. During the 18 months of follow up there were 55 cases of pertussis. The attack rate was 1·5% (8/525) among the vaccinated children and 7·6% (47/615) among the unvaccinated children (p<0·001). The estimated efficacy of the vaccine was 80% (95% confidence interval 58 to 90).The estimated efficacy of pertussis vaccine was similar to that observed in British trials over 30 years ago.     

国产甲型肝炎灭活疫苗用于儿童免疫效果研究

为了探讨国产甲型肝炎灭活疫苗在儿童中应用的免疫效果,选择2～15岁抗-HAV阴性健康易感儿童91名作为接种对象,采用0、6程序接种国产甲型肝炎灭活疫苗250U／剂,观察免疫后的局部反应和全身反应,并于全程免疫后一个月检测抗-HAV阳转率和抗体GMT。结果91例观察对象在初免和加强免疫后均未见即时副反应,只在8～72小时内出现轻微的一过性局部和全身反应。全程免疫后一个月抗-HAV阳转率为100％。抗体GMT为14 407mIU／ml。国产甲肝灭活疫苗在儿童中应用具有良好的安全性和免疫原性,采用0、6个月程序可获得高滴度抗体。     

Pertussis antibody levels in infants immunized with an acellular pertussis component vaccine, measured using whole-cell pertussis ELISA

A commercially available whole-cell pertussis IgG ELISA was used to test the response of 137 2-month-old infants to immunization with a trivalent acellular pertussis vaccine. The pre-immunization geometric mean (GM) IgG index was 6.96 (95% confidence interval (CI) 5.88-8.04) and the postimmunization GM index was 13.16 (95% CI 12. 20-14.11), P < 0.001. Eighty percent of subjects (110/137) had a significant 1.5-fold increase of pertussis IgG index (97/137, 71%) or a postimmunization IgG index > 10 (93/137, 68%). In single antigen ELISA, 83% showed at least a fourfold increase in pertussis toxin-specific IgG (PT-IgG) and 91% showed an increase in IgG specific for filamentous haemagglutinin (FHA-IgG). Four percent had high pre- immunization antibody levels (index > 20), likely to reflect recent maternal exposure to pertussis. This correlated with a smaller increase in pertussis IgG index. A decline in pertussis IgG index postimmunization occurred in 17/24 infants (71%) whose pre-immunization IgG index was > 10. This postimmunization pertussis IgG index was not significantly different to that of infants with a low pre-immunization index. A similar trend was noted with PT-IgG and FHA-IgG results. The whole-cell ELISA can detect a response to acellular pertussis vaccination in most infants if both antibody index and degree of seroconversion are calculated and at least one criterion is satisfied.     

Experience with vaccine prophylaxis of hepatitis B among different groups of children

The immunological activity of different vaccines against hepatitis B was evaluated in the Hepatological Center organized on the basis of the Infectious Hospital in Tula. Newborn infants were immunized with the use of the following vaccines: Engerix B (Belgium), Combiotech (Russia), Euvax B (Aventis Pastèur, South Korea). Altogether, after the full course of immunization anti-HBs were detected in 76 children out of 81 (in 93.8%). Vaccine Engerix B, when introduced according to the schedule 0-1-2-12 months, exhibited high immunogenic properties in a group of infants born of women with persistent HBs-antigenemia. Anti-HBs at a concentration exceeding 1000 I.U./I could be detected in 84.6%. In another group of children immunized according to the schedule 0-1-6 months first with vaccine Combiotech at the age of 0 and 1 month, then (at the age of 6 months) with vaccine Euvax, the presence of postvaccinal anti HBs at protective concentration was registered in all children. After immunization against hepatitis B with the use of all above-mentioned vaccines introduced according to both schedules high immunological activity and safety of immunization were noted.     

进口、国产人用狂犬病疫苗免疫后中和抗体水平测定

应用间接免疫荧光法（ＩＦＡ）检测１６６例不同产地（国产、进口）人用狂犬病疫苗免后血清抗体水平,结果：国产苗抗体阳转率为９５．４２％,ＧＭＴ为９．４８,进口苗抗体阳转率为６２．８５％,ＧＭＴ为４．３５。经统计学处理,二者差异有非常显著性意义（Ｘ２＝２８．６１Ｐ＜０．００５）,初步提示了国产的（浓缩）原代地鼠肾组织培养狂犬病疫苗比某进口ＶＥＲＯ细胞狂犬病疫苗免疫效果要好,是一种高效、安全、价格便宜的预防狂犬病免疫制品